237 related articles for article (PubMed ID: 20716141)
1. Is renoprotection with RAAS blockade a failed paradigm? Have we learnt any lessons so far?
Onuigbo MA
Int J Clin Pract; 2010 Sep; 64(10):1341-6. PubMed ID: 20716141
[No Abstract] [Full Text] [Related]
2. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
3. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.
Ahmed AK; Kamath NS; El Kossi M; El Nahas AM
Nephrol Dial Transplant; 2010 Dec; 25(12):3977-82. PubMed ID: 19820248
[TBL] [Abstract][Full Text] [Related]
4. Effects of suspending ACE inhibitors and ARBs in advanced chronic kidney disease.
Díaz-Domínguez ME; Fernández-Lucas M; Gomis-Couto A; Ruiz-Roso G; Teruel JL; Quereda C
Nefrologia; 2012 May; 32(3):400-1. PubMed ID: 22592428
[No Abstract] [Full Text] [Related]
5. Not yet time for a paradigm shift away from angiotensin inhibitors in chronic kidney disease, but due diligence required.
Swift PA; Andrews PA
Int J Clin Pract; 2010 Sep; 64(10):1331-3. PubMed ID: 20716138
[No Abstract] [Full Text] [Related]
6. [Debate concerning the optimal blockage of the renin-angiotensin system].
Choukroun G
Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
[No Abstract] [Full Text] [Related]
7. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
Hollenberg NK; Epstein M
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
[No Abstract] [Full Text] [Related]
8. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Azizi M; Ménard J
Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
[No Abstract] [Full Text] [Related]
9. [Renoprotection and blockade of the renin-angiotensin system: What shall we believe?].
Kamper AL; Feldt-Rasmussen B; Strandgaard S
Ugeskr Laeger; 2006 Apr; 168(15):1563. PubMed ID: 16640988
[No Abstract] [Full Text] [Related]
10. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
Rossing P; Parving HH; de Zeeuw D
Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724
[No Abstract] [Full Text] [Related]
11. Of fads, fashion, surrogate endpoints and dual RAS blockade.
Messerli FH; Staessen JA; Zannad F
Eur Heart J; 2010 Sep; 31(18):2205-8. PubMed ID: 20685681
[TBL] [Abstract][Full Text] [Related]
12. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
13. Progression of chronic kidney disease: can it be prevented or arrested?
Jaber BL; Madias NE
Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
[TBL] [Abstract][Full Text] [Related]
14. [Renin inhibition and the kidney].
Ecder T
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
[TBL] [Abstract][Full Text] [Related]
15. Nephroprotective action of renin-angiotensin-aldosterone system blockade in chronic kidney disease patients: the landscape after ALTITUDE and VA NEPHRON-D trails.
Rutkowski B; Tylicki L
J Ren Nutr; 2015 Mar; 25(2):194-200. PubMed ID: 25576239
[TBL] [Abstract][Full Text] [Related]
16. Clinical trials in progression of chronic renal failure.
Striker GE; Klahr S
Adv Intern Med; 1997; 42():555-95. PubMed ID: 9048130
[No Abstract] [Full Text] [Related]
17. Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema.
Makani H; Bangalore S; Romero J; Wever-Pinzon O; Messerli FH
Am J Med; 2011 Feb; 124(2):128-35. PubMed ID: 21295192
[TBL] [Abstract][Full Text] [Related]
18. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
Griffin KA; Bidani AK
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
[TBL] [Abstract][Full Text] [Related]
19. [Significance of RAAS inhibition in diabetic nephropathy].
Tsuruya K; Toyonaga J
Nihon Rinsho; 2012 Jul; 70 Suppl 5():411-8. PubMed ID: 23156430
[No Abstract] [Full Text] [Related]
20. Angiotensin receptor blockers: RAAS blockade and renoprotection.
Ruilope LM
Curr Med Res Opin; 2008 May; 24(5):1285-93. PubMed ID: 18366863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
